Samsung Biologics announces KRW 3 trillion rights offering
Samsung Biologics announced a KRW 3 trillion rights offering to fund its next-phase expansion.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.